T lymphocyte responses to myeloperoxidase, proteinase 3 and proteinase 3 peptides from patients with ANCA-associated systemic vasculitis.

被引：0
|
作者：
King, WJ
Brooks, CJ
Holder, R
Hughes, P
Ben-Smith, A
Adu, D
Savage, COS
机构：
[1] Univ Birmingham, Ctr Clin Res Immunol & Signalling, Birmingham, W Midlands, England
[2] Univ Birmingham, Dept Stat, Birmingham, W Midlands, England
[3] Queen Elizabeth Hosp, Dept Nephrol, Birmingham B15 2TT, W Midlands, England
来源：
KIDNEY INTERNATIONAL | 1999年 / 55卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2102 / 2102
页数：1
相关论文
共 50 条
  • [21] In vitro cytokine production and proliferation of T cells from patients with anti-proteinase 3-and antimyeloperoxidase-associated vasculitis, in response to proteinase 3 and myeloperoxidase
    Popa, ER
    Franssen, CFM
    Limburg, PC
    Huitema, MG
    Kallenberg, CGM
    Tervaert, JWC
    ARTHRITIS AND RHEUMATISM, 2002, 46 (07): : 1894 - 1904
  • [22] Co-expression of CD177 and membrane proteinase 3 on neutrophils in ANCA-associated vasculitis
    Hu, Nan
    Westra, Johanna
    Huitema, Minke
    Bijl, Marc
    Brouwer, Elithabeith
    Brouwer, Elisabeth
    Stegeman, Coen
    Limburg, Pieter
    Kallenberg, Cees
    APMIS, 2009, 117 : 119 - 119
  • [23] PROTEINASE 3-REACTIVE B CELL RECONSTITUTION AFTER TREATMENT WITH RITUXIMAB FOR ANCA-ASSOCIATED VASCULITIS
    Berti, A.
    Hillion, S.
    Hummel, A.
    Carmona, E.
    Peikert, T.
    Langford, C.
    Merkel, P. A.
    Monach, P.
    Seo, P.
    Spiera, R.
    St Clair, E. W.
    Fervenza, F.
    Harris, K.
    Stone, J. H.
    Pers, J. O.
    Specks, U.
    Cornec, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 229 - 229
  • [24] Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3 in ANCA-Associated Vasculitis
    Thompson, Gwen E.
    Fussner, Lynn A.
    Hummel, Amber M.
    Schroeder, Darrell R.
    Silva, Francisco
    Snyder, Melissa R.
    Langford, Carol A.
    Merkel, Peter A.
    Monach, Paul A.
    Seo, Philip
    Spiera, Robert F.
    St Clair, E. William
    Stone, John H.
    Specks, Ulrich
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [25] CLINICAL UTILITY OF SERIAL MEASUREMENTS OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES TARGETING PROTEINASE 3 IN ANCA-ASSOCIATED VASCULITIS
    Thompson, Gwen
    Fussner, Lynn
    Hummel, Amber
    Schroeder, Darrell
    Silva, Francisco
    Snyder, Melissa
    Kallenberg, Cees
    Langford, Carol
    Merkel, Peter
    Monach, Paul
    Seo, Philip
    Spiera, Robert
    St Clair, E. William
    Stone, John
    Specks, Ulrich
    RHEUMATOLOGY, 2019, 58
  • [26] Lymphocyte counts in patients with ANCA-associated vasculitis
    Andreas Holbro
    Philipp Schuetz
    Christoph Berger
    Christoph Hess
    Thomas Daikeler
    Rheumatology International, 2009, 29 : 807 - 810
  • [27] Lymphocyte counts in patients with ANCA-associated vasculitis
    Holbro, Andreas
    Schuetz, Philipp
    Berger, Christoph
    Hess, Christoph
    Daikeler, Thomas
    RHEUMATOLOGY INTERNATIONAL, 2009, 29 (07) : 807 - 810
  • [28] Long-term treatment results and the immunoglobulin G subclass distribution patterns of proteinase-3-antineutrophil cytoplasm antibody (ANCA) and myeloperoxidase-ANCA in ANCA-associated vasculitis
    Almroth, Gabriel
    Berlin, Gosta
    Andersson, Bengt
    Hahn-Zoric, Mirjana
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2009, 43 (02): : 160 - 170
  • [29] Autoantibodies to proteinase 3 and myeloperoxidase in systemic sclerosis
    Ruffatti, A
    Sinico, RA
    Radice, A
    Ossi, E
    Cozzi, F
    Tonello, M
    Grypiotis, P
    Todesco, S
    JOURNAL OF RHEUMATOLOGY, 2002, 29 (05) : 918 - 923
  • [30] COMPARISON OF LACTOFERRIN ANTIBODIES WITH MYELOPEROXIDASE OR PROTEINASE 3 ANTIBODIES (ANCA) IN SYSTEMIC-DISEASES
    APENBERG, S
    GOTZE, M
    ANDRASSY, K
    RITZ, E
    KIDNEY INTERNATIONAL, 1992, 41 (02) : 478 - 478
12345